Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Gynatren

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Problem: Alle antimykotischen Therapien bei chronisch rezidivierender Vaginalkandidose (CRVC) sind unbefriedigend, solange es… Expand
Is this relevant?
1991
1991
167 patients suffering from nonspecific bacterial vaginoses were vaccinated in a double-blind, randomized, placebo-controlled… Expand
Is this relevant?
1989
1989
52 infertile women (age range 19-35 years) treated by Gynatren-immunopotentialization (three vaccinations every second week) were… Expand
Is this relevant?
1989
1989
Sixty one women (age range 20-35 years) treated by Gynatren-immunopotentialization (three vaccinations every second week) were… Expand
Is this relevant?
1984
1984
  • G. Karkut
  • Geburtshilfe und Frauenheilkunde
  • 1984
  • Corpus ID: 8226452
In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac… Expand
Is this relevant?
1984
1984
In three different laboratory studies an attempt was made to elucidate the mechanism of action of the immunotherapeutic Gynatren… Expand
Is this relevant?
Review
1984
Review
1984
The results obtained in the treatment of 69 patients with trichomonal vaginitis and 46 patients with bacterial vaginitis with the… Expand
Is this relevant?
1984
1984
An explanation of the mode of action of the vaccine Gynatren/SolcoTrichovac is presented based on known immunological mechanisms… Expand
Is this relevant?